Sign In
Buy CTRE
CareTrust REIT Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.393 |
| EPS actual | $0.480 |
| EPS Surprise | 22.29% |
| Revenue estimate | 112.849M |
| Revenue actual | 114.196M |
| Revenue Surprise | 1.19% |
| Release date | Feb 12, 2026 |
| EPS estimate | $0.390 |
| EPS actual | $0.470 |
| EPS Surprise | 20.51% |
| Revenue estimate | 110.67M |
| Revenue actual | 106.25M |
| Revenue Surprise | -3.99% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.470 |
| EPS actual | $0.450 |
| EPS Surprise | -4.26% |
| Revenue estimate | 130.454M |
| Revenue actual | 104.265M |
| Revenue Surprise | -20.08% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.450 |
| EPS actual | $0.430 |
| EPS Surprise | -4.44% |
| Revenue estimate | 102.024M |
| Revenue actual | 112.469M |
| Revenue Surprise | 10.24% |
Last 4 Quarters for CareTrust REIT
Below you can see how CTRE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $32.65 |
| EPS estimate | $0.450 |
| EPS actual | $0.430 |
| EPS surprise | -4.44% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $31.80 |
| Aug 01, 2025 | $31.99 |
| Aug 04, 2025 | $32.90 |
| Aug 05, 2025 | $32.79 |
| Aug 06, 2025 | $32.65 |
| Aug 07, 2025 | $32.55 |
| Aug 08, 2025 | $32.90 |
| Aug 11, 2025 | $32.87 |
| Aug 12, 2025 | $32.99 |
| 4 days before | 2.67% |
| 4 days after | 1.04% |
| On release day | -0.306% |
| Change in period | 3.74% |
| Release date | Nov 05, 2025 |
| Price on release | $36.00 |
| EPS estimate | $0.470 |
| EPS actual | $0.450 |
| EPS surprise | -4.26% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $34.35 |
| Oct 31, 2025 | $34.65 |
| Nov 03, 2025 | $35.31 |
| Nov 04, 2025 | $35.39 |
| Nov 05, 2025 | $36.00 |
| Nov 06, 2025 | $35.56 |
| Nov 07, 2025 | $36.15 |
| Nov 10, 2025 | $36.65 |
| Nov 11, 2025 | $36.50 |
| 4 days before | 4.80% |
| 4 days after | 1.39% |
| On release day | -1.22% |
| Change in period | 6.26% |
| Release date | Feb 12, 2026 |
| Price on release | $40.14 |
| EPS estimate | $0.390 |
| EPS actual | $0.470 |
| EPS surprise | 20.51% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $38.84 |
| Feb 09, 2026 | $38.41 |
| Feb 10, 2026 | $38.74 |
| Feb 11, 2026 | $39.39 |
| Feb 12, 2026 | $40.14 |
| Feb 13, 2026 | $40.01 |
| Feb 17, 2026 | $41.12 |
| Feb 18, 2026 | $40.15 |
| Feb 19, 2026 | $39.94 |
| 4 days before | 3.35% |
| 4 days after | -0.498% |
| On release day | -0.324% |
| Change in period | 2.83% |
| Release date | May 07, 2026 |
| Price on release | $39.51 |
| EPS estimate | $0.393 |
| EPS actual | $0.480 |
| EPS surprise | 22.29% |
| Date | Price |
|---|---|
| May 01, 2026 | $39.19 |
| May 04, 2026 | $39.50 |
| May 05, 2026 | $39.34 |
| May 06, 2026 | $39.48 |
| May 07, 2026 | $39.51 |
| May 08, 2026 | $41.60 |
| May 11, 2026 | $40.51 |
| May 12, 2026 | $42.09 |
| May 13, 2026 | $42.44 |
| 4 days before | 0.82% |
| 4 days after | 7.42% |
| On release day | 5.29% |
| Change in period | 8.29% |
CareTrust REIT Earnings Call Transcript Summary of Q1 2026
CareTrust REIT started 2026 with strong execution across acquisitions, operations, and capital markets. The company closed approximately $245 million of investments in Q1 and an additional ~$865 million since April, bringing year-to-date investments to about $1.1 billion at a blended stabilized yield near 8.9%. The current near-term pipeline is ~ $360 million, weighted toward UK care homes and SHOP opportunities. Operating fundamentals and tenant quality remain strong: the stabilized triple-net portfolio shows EBITDAR rent coverage of 2.25x (EBITDARM 2.79x), and the company collected 100% of contractual rent and interest in Q1. Reported normalized FFO for the quarter rose materially (normalized FFO increased 38% year-over-year, and normalized FFO per share rose 14% to $0.48); normalized FAD per share also increased. Management raised full-year 2026 FFO and FAD guidance (midpoints ~14.8% and 13.6% above 2025, respectively) and increased the dividend by 16.4%. Credit profile strengthened with a Moody’s upgrade to investment grade. Balance sheet and liquidity are robust: $70M cash, $350M drawn on a $1.2B revolver (leaving ~$850M availability), sizeable ATM capacity, and very low leverage (net debt / annualized normalized EBITDA ~0.6x). Strategy emphasizes disciplined, operator-focused underwriting across three growth engines (U.S. skilled nursing, SHOP, and UK care homes), opportunistic lending tied to real estate, and selective expansion in SHOP despite heightened competition and cap-rate compression. Guidance assumptions and risks include no additional investments or financings beyond YTD activity for guidance, sterling/dollar exchange rate stability, and the company’s stated accounting/timing conventions for certain sale-leaseback vs. financing receivable structures.
